Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 3—March 2007

Research

Population-based Laboratory Surveillance for AmpC β-Lactamase–producing Escherichia coli, Calgary

Johann D.D. Pitout*Comments to Author , Daniel B. Gregson*, Deirdre L. Church*, and Kevin B. Laupland*
Author affiliations: *University of Calgary, Calgary, Alberta, Canada;

Main Article

Table

Features of Escherichia coli β-lactamases isolated from Calgary Health Region, 2000–2003

Feature*CMY types (n = 125), no. (%)Non-CMY types (n = 244), no. (%)p value
Female105 (84)205 (84)1.0
Community-onset104 (83)204 (84)1.0
Resistant to
  Ciprofloxacin10 (8)23 (9)0.6
  Gentamicin28 (22)26 (11)0.004
  Tobramycin13 (10)19 (8)0.4
  Trimethoprim-sulfamethoxazole29 (23)44 (18)0.3

*Median age for those with CMY types was 54.3 (interquartile range 27.7–76.1); median age for those with non-CMY types was 50.5 (interquartile range 26.6–73.3).

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO